Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @OncLive
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @OncLive
-
Pembrolizumab Shows Promise in Small Cell Lung Cancer
#lcsmhttp://www.onclive.com/web-exclusives/pembrolizumab-shows-promise-in-small-cell-lung-cancer …Thanks. Twitter will use this info to make your timeline better. Undo -
John Mendelsohn, MD, served as president of The University of Texas MD Anderson Cancer Center for a 15-year periodhttp://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/mendelsohns-antibody-research-reverberates-today …
Thanks. Twitter will use this info to make your timeline better. Undo -
Role of 5-HT3 Receptor Antagonists in Treating CINVhttp://ht.ly/kBkN30eLxZq
Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer
#pcsm@UWhttp://www.onclive.com/onclive-tv/dr-higano-on-the-effectiveness-of-parp-inhibitors-for-prostate-cancer …Thanks. Twitter will use this info to make your timeline better. Undo -
In July 2017, the FDA’s ODAC voted 16-0 to recommend approval of MYL-1401Ohttp://www.onclive.com/web-exclusives/fda-delays-decision-on-trastuzumab-biosimilar-myl1401o …
Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Nathanson on how the BRCA1/2 tumors impacts tumor development in breast and ovarian cancer
#bcsm#gyncsmhttp://www.onclive.com/web-exclusives/brca12-mutation-genetic-status-linked-with-platinum-resistance-in-breast-and-ovarian-cancers …Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Esteva on the Clinical Implications of Genomic Testing for Breast Cancer
#bcsm@nyulangonehttp://www.onclive.com/onclive-tv/dr-esteva-on-the-clinical-implications-of-genomic-testing-for-breast-cancer …Thanks. Twitter will use this info to make your timeline better. Undo -
There have been recent developments in using scalp cooling to combat chemotherapy-induced alopecia
#bcsmhttp://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/baylor-team-helps-establish-scalpcooling-benefits-for-breast-cancer-patients …Thanks. Twitter will use this info to make your timeline better. Undo -
CAR T-cell therapy tisagenlecleucel is going to be on the market at a price of $475,000 for a single infusion
#leusmhttp://www.onclive.com/web-exclusives/novartis-sets-a-price-of-475000-for-car-tcell-therapy …Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Roboz on Impact of the FDA Approval of CTL019 in ALL
#leusm@WeillCornell@US_FDAhttp://www.onclive.com/onclive-tv/dr-roboz-on-impact-of-ctl019-in-all …Thanks. Twitter will use this info to make your timeline better. Undo -
ODAC voted 10-0 to recommend approval of tisagenlecleucel for pediatric ALL
#leusmhttp://www.onclive.com/web-exclusives/fda-oks-tisagenlecleucel-in-all-as-first-approved-car-tcell-therapy …Thanks. Twitter will use this info to make your timeline better. Undo -
Why has it been so difficult to successfully conduct definitive trials?http://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/theres-a-growing-need-to-look-under-the-hood-of-the-clinical-trial-model …
Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast Cancer
#bcsm@DanaFarberhttp://www.onclive.com/onclive-tv/dr-tolaney-on-the-neoadjuvant-therapy-for-her2positive-breast-cancer …Thanks. Twitter will use this info to make your timeline better. Undo -
The FDA has extended its decision deadline by 3 months on a biologics license application for MYL-1401Ohttp://www.onclive.com/web-exclusives/fda-delays-decision-on-trastuzumab-biosimilar-myl1401o …
Thanks. Twitter will use this info to make your timeline better. Undo -
BRCA1/2 Mutation Genetic Status Linked With Platinum Resistance in Breast and Ovarian Cancers
#bcsm@PennMedicinehttp://www.onclive.com/web-exclusives/brca12-mutation-genetic-status-linked-with-platinum-resistance-in-breast-and-ovarian-cancers …Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Bunn on the MYSTIC Trial for Lung Cancer
#lcsmhttp://www.onclive.com/onclive-tv/dr-bunn-on-the-mystic-trial-for-lung-cancer …Thanks. Twitter will use this info to make your timeline better. Undo -
Mendelsohn's Antibody Research Reverberates Today
@MDAndersonNewshttp://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/mendelsohns-antibody-research-reverberates-today …Thanks. Twitter will use this info to make your timeline better. Undo -
Baylor Team Helps Establish Scalp-Cooling Benefits for Breast Cancer
#bcsm@Baylorhttp://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/baylor-team-helps-establish-scalpcooling-benefits-for-breast-cancer-patients …Thanks. Twitter will use this info to make your timeline better. Undo -
Dr. Lallas on the Future of Immunotherapy in Genitourinary Malignancieshttp://www.onclive.com/onclive-tv/dr-lallas-on-the-future-of-immunotherapy-in-genitourinary-malignancies …
Thanks. Twitter will use this info to make your timeline better. Undo -
Studies conducted illustrate the shortcomings of the clinical trial model that has dominated the oncology spherehttp://www.onclive.com/publications/oncology-live/2017/vol-18-no-17/theres-a-growing-need-to-look-under-the-hood-of-the-clinical-trial-model …
Thanks. Twitter will use this info to make your timeline better. Undo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
